Codi QR

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

BackgroundPirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF).ObjectiveTo investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting.MethodsThis was a multicenter, retrospective, real-l...

Descripció completa

Guardat en:
Autors principals: Argyrios Tzouvelekis, Theodoros Karampitsakos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Evangelos Markozannes, Ioanna Malliou, Aris Anagnostopoulos, Andreas Granitsas, Paschalis Steiropoulos, Katerina Dimakou, Serafeim Chrysikos, Nikolaos Koulouris, Demosthenes Bouros
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017-11-01
Col·lecció:Frontiers in Medicine
Matèries:
pirfenidone
safety
efficacy
idiopathic pulmonary fibrosis
treatment
Accés en línia:http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars